00

Apeloa Pharmaceutical Co LtdSHE 000739 Stock Report

Last reporting period 30 Sep, 2023

Updated 18 Sep, 2024

Last price

Market cap $B

2.401

Small

Exchange

XSHE - Shenzhen Stock Exchange

000739.SZ Stock Analysis

00

Uncovered

Apeloa Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

60/100

Moderate score

Market cap $B

2.401

Dividend yield

2.02 %

Shares outstanding

1 170.95 B

Apeloa Pharmaceutical Co., Ltd. engages in research, development, and production of active pharmaceutical ingredient (API) intermediates, contract development and production services (CDMO), and preparations. The company is headquartered in Jinhua, Zhejiang and currently employs 6,133 full-time employees. The Company’s main products consist of bulk drugs, intermediates, chemical preparations, as well as Chinese traditional medicine preparations, such as ubenimex capsules, cefixime, amantadine and others. The firm distributes its businesses in domestic market and to overseas markets.

View Section: Eyestock Rating